Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection

10.1016/j.antiviral.2019.104637

Saved in:
Bibliographic Details
Main Authors: Loe, MWC, Lee, RCH, Chu, JJH
Other Authors: MICROBIOLOGY AND IMMUNOLOGY
Format: Article
Published: Elsevier BV 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/173210
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-173210
record_format dspace
spelling sg-nus-scholar.10635-1732102024-03-27T08:15:17Z Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection Loe, MWC Lee, RCH Chu, JJH MICROBIOLOGY AND IMMUNOLOGY Antiviral FDA-approved compounds High-throughput screening Zika 10.1016/j.antiviral.2019.104637 Antiviral Research 172 104637- completed 2020-08-21T00:11:48Z 2020-08-21T00:11:48Z 2019-12-01 2020-06-23T07:22:04Z Article Loe, MWC, Lee, RCH, Chu, JJH (2019-12-01). Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection. Antiviral Research 172 : 104637-. ScholarBank@NUS Repository. https://doi.org/10.1016/j.antiviral.2019.104637 01663542 18729096 https://scholarbank.nus.edu.sg/handle/10635/173210 Elsevier BV Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic Antiviral
FDA-approved compounds
High-throughput screening
Zika
spellingShingle Antiviral
FDA-approved compounds
High-throughput screening
Zika
Loe, MWC
Lee, RCH
Chu, JJH
Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection
description 10.1016/j.antiviral.2019.104637
author2 MICROBIOLOGY AND IMMUNOLOGY
author_facet MICROBIOLOGY AND IMMUNOLOGY
Loe, MWC
Lee, RCH
Chu, JJH
format Article
author Loe, MWC
Lee, RCH
Chu, JJH
author_sort Loe, MWC
title Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection
title_short Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection
title_full Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection
title_fullStr Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection
title_full_unstemmed Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection
title_sort antiviral activity of the fda-approved drug candesartan cilexetil against zika virus infection
publisher Elsevier BV
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/173210
_version_ 1795300962219327488